Singapore vs Spain: Number of isolates tested for ceftriaxone
Singapore
232
in 2020
Spain
232
in 2020
Singapore rank
13th
Spain rank
13th
Number of isolates tested for ceftriaxone over time
- Singapore
- Spain
How they compare
Singapore currently reports 232 against 232 in Spain, a difference of 0.
The two have swapped places 5 times across 10 shared years of data; in 2009 it was Singapore ahead.
Singapore ranks 13th and Spain ranks 13th of 52 countries.
Across the 3 decades both report, Singapore averaged higher in 1 and Spain in 1.
Head to head by decade
| Decade | Singapore | Spain | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 160 | 103 | 57 | Singapore |
| 2010s | 100.25 | 195.88 | 95.62 | Spain |
| 2020s | 232 | 232 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Singapore or Spain?
- Singapore, at 232 against 232 in Spain as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Singapore and Spain?
- 0, with Singapore ahead.
- How many years of comparable data are there for Singapore and Spain?
- 10 years are reported by both, from 2009 to 2020.
- How do Singapore and Spain rank globally for number of isolates tested for ceftriaxone?
- Singapore ranks 13th and Spain ranks 13th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.